D. Cross

发表

Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow.

H. White, H. Hart, J. French, 1999, Journal of the American College of Cardiology.

Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression.

H. White, H. Hart, J. French, 1995, British heart journal.

Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.

H. White, R. Norris, J. Elliott, 1994, Circulation.

Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk.

H. White, R. Norris, N. Ashton, 1991, Journal of the American College of Cardiology.

Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking.

H. White, R. Norris, J. Rivers, 1990, Journal of the American College of Cardiology.

Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy.

H. White, H. White, S. Cederholm-Williams, 1993, The American journal of cardiology.

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities.

T. S. Chee, D. S. Kim, S. H. Lee, 2021, European journal of preventive cardiology.

Detection of reperfusion after thrombolytic therapy by the analysis of released biochemical markers.

D. Cross, 1998, Australian and New Zealand journal of medicine.

Allergic Reactions to Streptokinase

D. Cross, Dr Harvey D. White, 1994, Clinical Immunotherapeutics.

"Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction.

H. White, J. Ormiston, K. Woo, 1995, The American journal of cardiology.

Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.

H. White, J. Ormiston, J. French, 1995, Journal of the American College of Cardiology.

Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis.

H. White, K. Woo, R. Norris, 1993, British heart journal.

ePLAR - The echocardiographic Pulmonary to Left Atrial Ratio - A novel non-invasive parameter to differentiate pre-capillary and post-capillary pulmonary hypertension.

D. Burstow, G. Scalia, D. Platts, 2016, International journal of cardiology.

Clinical Exercise Stress Testing in Adults (2014).

R. Zecchin, D. Colquhoun, D. Hare, 2015, Heart, lung & circulation.

Reduced synthesis of tissue plasminogen activator by vascular endothelium during acute myocardial infarction.

H. White, M. Takayama, R. Norris, 1992, Australian and New Zealand journal of medicine.

Should streptokinase be readministered?

D. Cross, David B Cross, 1994, The Medical journal of Australia.

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

J. Le Heuzey, J. Healey, J. Camm, 2019, Thrombosis Journal.

Genesis of improved quality in imaging through a national Australian echocardiography registry

P. Disney, D. Eccleston, Xiao-fang Xu, 2022, Open Heart.

Aspirin does not improve early arterial patency after streptokinase treatment for acute myocardial infarction.

H. White, A. Maslowski, H. Hart, 1993, British heart journal.

acute myocardial infarction . patency after streptokinase treatment for Aspirin does not improve early arterial

H. White, R. Norris, A. Maslowski, 2022 .

Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.

H. White, R. Norris, B. Williams, 1990, British heart journal.

treatment after acute myocardial infarction . Safety and efficacy of repeat thrombolytic

H. White, R. Norris, B. Williams, 2022 .

Effect of preoperative supplementation with alpha-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations.

M. Frenneaux, S. J. Fleming, J. Westhuyzen, 1997, The Journal of thoracic and cardiovascular surgery.

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina

Gebhardt, D. DeMets, A. Capucci, 1998 .

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

G. Breithardt, H. Crijns, P. Mclaughlin, 2016, Journal of the American Heart Association.

Prognosis after recovery from myocardial infarction: the relative importance of cardiac dilatation and coronary stenoses.

R M Whitlock, H. White, C. Wild, 1992, European heart journal.

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities.

T. S. Chee, D. S. Kim, S. H. Lee, 2022, European journal of preventive cardiology.

Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage.

J. Atherton, W. Miles, N. Parekh, 2000, Journal of the American College of Cardiology.